Zenith Drugs Management
Management criteria checks 3/4
Zenith Drugs' CEO is Sandeep Bhardwaj, appointed in Sep 2023, has a tenure of less than a year. directly owns 23.33% of the company’s shares, worth ₹240.40M. The average tenure of the management team and the board of directors is 4.8 years and 4.8 years respectively.
Key information
Sandeep Bhardwaj
Chief executive officer
₹4.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 23.3% |
| Management average tenure | 4.8yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO
Sandeep Bhardwaj (45 yo)
less than a year
Tenure
₹4,800,000
Compensation
Mr. Sandeep Bhardwaj is Chief Financial Officer, Managing Director since September 16, 2023 & Director since October 31, 2003 of Zenith Drugs Limited. He has completed his degree of Bachelor in Pharmacy fr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CFO, MD & Director | less than a year | ₹4.80m | 23.33% ₹ 240.4m | |
| Executive Director | 23.2yrs | ₹3.60m | 23.33% ₹ 240.4m | |
| Executive Director | 8.9yrs | ₹306.00k | 23.33% ₹ 240.4m | |
| Company Secretary & Compliance Officer | less than a year | no data | no data |
4.8yrs
Average Tenure
44.5yo
Average Age
Experienced Management: ZENITHDRUG's management team is considered experienced (4.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CFO, MD & Director | 20.6yrs | ₹4.80m | 23.33% ₹ 240.4m | |
| Executive Director | 23.2yrs | ₹3.60m | 23.33% ₹ 240.4m | |
| Executive Director | 8.9yrs | ₹306.00k | 23.33% ₹ 240.4m | |
| Non- Executive Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
4.8yrs
Average Tenure
45yo
Average Age
Experienced Board: ZENITHDRUG's board of directors are considered experienced (4.8 years average tenure).